Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,201–5,225 of 7,816 matching trials · page 209 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Comparisons of gaIt aNalyses pERformance Between the Gaitrite walkwaYs NCT04557592 Runs in: France · 1 site |
NA other |
COMPLETED | 98 | University Hospital, Angers OTHER_GOV |
2020-09-21 |
|
Tricaprilin In Age-Associated Memory Impairment NCT00355550 Tricaprilin; Placebo Runs in: United States · 6 sites |
PHASE2 other |
COMPLETED | 156 | Cerecin INDUSTRY |
2020-09-18 |
|
Curcumin and Yoga Therapy for Those at Risk for Alzheimer's Disease NCT01811381 Curcumin; aerobic yoga; non aerobic yoga; Placebo Runs in: United States · 1 site |
PHASE2 other |
UNKNOWN | 80 | VA Office of Research and Development OTHER_GOV |
2020-09-17 |
|
Memory for Action in Neurological Patients NCT02844855 Cognitive tests Runs in: France · 2 sites |
NA other |
TERMINATED | 83 | Centre Hospitalier Universitaire de Saint Etienne OTHER |
2020-09-17 |
|
Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease NCT02500784 Formoterol A; Formoterol B (placebo) Runs in: United States · 1 site |
PHASE2 other |
WITHDRAWN | 0 | Palo Alto Veterans Institute for Research OTHER |
2020-09-16 |
|
Movement and Music Intervention for Individuals With Dementia NCT03121950 Dance; Music Runs in: United States · 1 site |
NA other |
COMPLETED | 21 | Ohio State University OTHER |
2020-09-16 |
|
Music and Physical Activity in Persons With Dementia NCT03447444 music and physical activity Runs in: Norway · 1 site |
NA other |
COMPLETED | 8 | Oslo Metropolitan University OTHER |
2020-09-16 |
|
Advanced Cognitive Stimulation Therapy (ACST) NCT04550975 Advanced Cognitive Stimulation Therapy |
NA other |
UNKNOWN | 32 | University College, London OTHER |
2020-09-16 |
|
Cognitive Impairment in Ageing People NCT04360200 Runs in: China · 1 site |
NA other |
RECRUITING | 5,000 | Yamei Tang OTHER |
2020-09-14 |
|
Mindful-Compassion Art Therapy for Dementia Care (MCAT-DC) : A Waitlist Randomized Controlled Trial NCT04548089 Mindful-Compassion Art Therapy for Dementia Care (MCAT-DC) Runs in: Singapore · 3 sites |
NA other |
UNKNOWN | 102 | Nanyang Technological University OTHER |
2020-09-14 |
|
A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and Comorbidity Pilot NCT02335125 Motivational Interviewing; Cognitive Behavioral Therapy Elements; P... |
NA other |
COMPLETED | 40 | University of Washington OTHER |
2020-09-11 |
|
Randomized Evaluation of Default Access to Palliative Services NCT02505035 Default ordering of palliative consult Runs in: United States · 11 sites |
NA other |
COMPLETED | 34,239 | University of Pennsylvania OTHER |
2020-09-11 |
|
Lexical Priming by Music in Alzheimer's Disease and Healthy Aging NCT03342326 Exposure to familiar songs; Music Experience Questionnaire; Implici... Runs in: France · 1 site |
NA other |
TERMINATED | 58 | Centre Hospitalier Universitaire de Saint Etienne OTHER |
2020-09-11 |
|
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD) NCT00459693 [11C]PBR28 Runs in: United States · 1 site |
NA other |
TERMINATED | 40 | National Institute of Mental Health (NIMH) NIH |
2020-09-10 |
|
Tau Imaging in Professional Fighters NCT02278354 Flortaucipir F18; Brain PET scan Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 35 | Avid Radiopharmaceuticals INDUSTRY |
2020-09-10 |
|
Clinical Evaluation of Flortaucipir F 18 NCT02278367 Flortaucipir F18; Brain PET scan Runs in: United States · 5 sites |
PHASE2 other |
COMPLETED | 179 | Avid Radiopharmaceuticals INDUSTRY |
2020-09-10 |
|
A Novel Machine Learning Algorithm to Predict the Lewy Body Dementias NCT04448340 machine learning model Runs in: Greece · 1 site |
NA other |
UNKNOWN | 200 | National and Kapodistrian University of Athens OTHER |
2020-09-10 |
|
Efficacy and Safety of MMFS in Early AD NCT03531684 MMFS-205-SR; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 10 | Neurocentria, Inc. INDUSTRY |
2020-09-09 |
|
A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation NCT03901092 flortaucipir F 18 Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 242 | Avid Radiopharmaceuticals INDUSTRY |
2020-09-09 |
|
Effects of Combined Cognitive Training With Aerobic Exercise in Stroke Patients With MCI NCT04012866 Aerobic exercise training; Computerized cognitive training; Control... Runs in: Taiwan · 4 sites |
NA other |
UNKNOWN | 75 | Chang Gung Memorial Hospital OTHER |
2020-09-09 |
|
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects NCT01992380 Flortaucipir F18; Brain PET scan Runs in: United States · 2 sites |
PHASE1 other |
COMPLETED | 24 | Avid Radiopharmaceuticals INDUSTRY |
2020-09-07 |
|
Imaging Characteristics of a Follow-up 18F-AV-1451 Scan NCT02051764 Flortaucipir F18; Florbetapir F 18; Brain PET Scan Runs in: United States · 4 sites |
PHASE2 other |
TERMINATED | 44 | Avid Radiopharmaceuticals INDUSTRY |
2020-09-07 |
|
18F-AV-1451 Autopsy Study NCT02516046 Flortaucipir F18; PET Scan Runs in: Australia; United States · 31 sites |
PHASE3 other |
COMPLETED | 156 | Avid Radiopharmaceuticals INDUSTRY |
2020-09-07 |
|
n-3 PUFA for Vascular Cognitive Aging NCT01953705 Omega 3 PUFA; Placebo Runs in: United States · 1 site |
PHASE2 other |
UNKNOWN | 102 | Oregon Health and Science University OTHER |
2020-09-04 |
|
Study of LM11A-31-BHS in Mild-moderate AD Patients NCT03069014 400mg LM11A-31-BHS; 800mg LM11A-31-BHS; Placebos Runs in: Austria; Czechia; Germany; Spain; Sweden · 21 sites |
PHASE1|PHASE2 other |
COMPLETED | 242 | PharmatrophiX Inc. INDUSTRY |
2020-09-04 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial